Simon Pedder
Chief Executive Officer, Chelsea Therapeutics International, Ltd.
Companies
- ADAPTIN BIO, INC.Chair Feb 18, 2025 to now1
- Athenex, Inc.Officer Jun 13, 2017 to Aug 5, 20212
- Avalo Therapeutics, Inc.Chair Apr 17, 2019 to Apr 13, 20203
- Avalo Therapeutics, Inc.Board member Apr 10, 2018 to Apr 1, 20194
- Delcath Systems, Inc.Board member Feb 5, 2019 to Feb 5, 20195
- Oncotelic Therapeutics, Inc.Board member Mar 23, 2016 to Jun 22, 20186
- Cellectar Biosciences, Inc.Board member Aug 18, 2014 to Aug 22, 20147
- Cellectar Biosciences, Inc.Chief executive officer Aug 18, 2014 to Aug 22, 20147
- Cellectar Biosciences, Inc.President Aug 18, 2014 to Aug 22, 20147
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ADAPTIN BIO, INC. APTN928,571 shares8$5.8M at $6.27Sep 10, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARADAPTIN BIO, INC., Chair
- 2SEC EDGARAthenex, Inc., Officer
- 3SEC EDGARAvalo Therapeutics, Inc., Chair
- 4
- 5SEC EDGARDelcath Systems, Inc., Board member
- 6
- 7
- 8